CSL Ltd. (a biotech company) has a substantially higher P/E ratio than the ASX200 index. Consider the
Fantastic news! We've Found the answer you've been seeking!
Question:
CSL Ltd. (a biotech company) has a substantially higher P/E ratio than the ASX200 index. Consider the P/E ratio as a short-hand version of DCF valuation model,
a) Identify the three fundamental determinants of P/E ratio and explain the relation of each determinant to valuation?
b) Does this higher P/E ratio indicate that CSL is traded at a premium or discount relative to the market? Explain why this is the case based on perspective of fundamental determinants of P/E ratio identified?
c) This difference in the P/E ratio increased after the Covid breakout. What does it tell us about the market's expectations?
Related Book For
Interpreting and Analyzing Financial Statements
ISBN: 978-0132746243
6th edition
Authors: Karen P. Schoenebeck, Mark P. Holtzman
Posted Date: